Related Experiment Video
Updated: Jul 6, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Complementary medicine in Germany.
Summary
Complementary medicine use varies significantly across Germany. A study in West Pomerania found only 6% usage, contrasting with 62% nationally, influenced by historical health policies.
Area of Science:
- Public Health
- Sociology of Health
- Medical History
Background:
- Complementary medicine use shows significant national and regional disparities.
- Understanding the drivers of these differences is crucial for public health.
- Historical health policies and healthcare system structures may play a role.
Discussion:
- The 1-year prevalence of complementary medicine use in West Pomerania, Germany, is 6%.
- This contrasts sharply with the 62% prevalence in the rest of Germany.
- Factors contributing to this disparity include historical health policies from the Nazi era and the former East German government, alongside the private healthcare nature of some complementary medicine.
Key Insights:
- Historical political and economic factors significantly shape current complementary medicine utilization.
- Regional variations in healthcare access and policy impact public health trends.
- The private healthcare aspect of complementary medicine influences its accessibility and adoption rates.
Outlook:
- Further research is needed to explore the long-term impact of historical policies on healthcare choices.
- Comparative studies across different regions can illuminate the complex interplay of policy, economics, and healthcare preferences.
- Investigating the evolving landscape of complementary medicine and its integration into national health systems is essential.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...